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Introduction – The critical sociodemographic, lifestyle and diseases factors influencing sarcopenia, 
defined by the current European Working Group on Sarcopenia 2 (EWGSOP2) classification and cut-
off points, have not yet been fully elucidated. This study aimed, therefore, to determine socio-
demographic, anthropometric, lifestyle and health-related factors associated with sarcopenia using 
the new EWGSOP2  definition.  
Study design – 396,283 participants (52.8% women, age 38-73 years) were included in this cross-
sectional study. The potential factors associated with sarcopenia were allocated to four categories: 
sociodemographic (sex, age, education, income and professional qualification), anthropometric 
(nutritional status, abdominal obesity, body fat and birth weight), lifestyle (physical activity, smoking, 
sleeping and sitting time, TV viewing, alcohol, and dietary intakes) and health status (self-reported 
prevalent diseases). P-values were corrected for multiple testing using the Bonferroni method. 
Results – Age, women, lower education, higher deprivation, underweight, lower birth weight, and 
chronic diseases such as rheumatoid arthritis, chronic bronchitis and osteoporosis were associated 
with a higher likelihood of sarcopenia. Conversely, overweight, obese, as well as a self-reported higher 
intake of energy, protein, vitamins ( B12 and B9) and minerals (potassium, calcium and magnesium) 
were associated with lower odds of sarcopenia. 
Conclusion – Women, adults older than 65 years, underweight people and those with rheumatoid 
arthritis were most likely to have sarcopenia. Considering the increase in the ageing population, 
sarcopenia is likely to become more prevalent. Identifying factors associated with sarcopenia could 
inform future strategies for early identification of individuals at high risk of sarcopenia and therefore, 
the implementation of preventive strategies against the disease. 




Sarcopenia is a progressive syndrome characterised by a decline in both the quality and quantity of 
muscle mass and is associated with a higher risk of disability and lower quality of life [1, 2].  Sarcopenia 
is an independent risk factor for falls, hospitalisation length, osteoporosis, cardiovascular diseases and 
mortality [1]. As a result, many interventions have been developed to investigate and attempt to 
prevent or delay sarcopenia and its associated consequences. 
Although previous cross-sectional studies have identified an increasing number of factors associated 
with sarcopenia; including sociodemographic (age, sex, education) and lifestyle (physical activity and 
diet) factors [1-7], previous findings have been inconsistent and limited to traditional factors [2, 4, 5]. 
In this context, extending current evidence to other factors, such as prevalent diseases and 
micronutrient intake, could help to elucidate novel factors which are associated with sarcopenia and 
therefore where new interventions could be developed or targeted.                               
 In addition, the European Working Group On Sarcopenia (EWGSOP) has recently updated the 
sarcopenia definition (EWGSOP2) [1], which has considerably reduced the number of people classified 
as having sarcopenia because the new definition has decreased the cut-off points of the physical 
capability markers [8-10]. Therefore, the results from studies that applied the previous definition of 
sarcopenia may no longer apply.  In this context, this study aimed to determine socio-demographic, 
anthropometric, lifestyle and health-related factors associated with sarcopenia among UK Biobank 
participants, using the new EWGSOP2  definition. 
2. Methods 
This was a cross-sectional study, using data collected at the UK Biobank baseline clinic, to assess the 
associations between different factors and sarcopenia. Due to ethnic differences in the reference 
values for sarcopenia, inclusion in the study was restricted to white European participants. Further 
information about UK biobank is available in supplementary methods.  
This paper is reported in adherence to the strengthening the reporting of observational studies in 
epidemiology (STROBE) statement [11]. 
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2.1 Sarcopenia definition 
Sarcopenia was defined as low grip strength plus low muscle mass using the current EWGSOP2 
classification and cut-off points [1]. More details about sarcopenia classification and its cut-off points 
are available in supplementary methods. 
2.2 Potential factors for sarcopenia 
Four categories of factors were investigated: sociodemographic (sex, age, education, income and 
professional qualification), anthropometric (nutritional status, abdominal obesity, body fat and birth 
weight), lifestyle (physical activity, sitting time, smoking, sleeping time, TV viewing, alcohol, and macro 
and micronutrients) and health status (prevalent diseases). 
2.2.1 Sociodemographic  
Age was calculated from dates of birth and baseline assessment. Townsend deprivation index, 
professional qualification and gross income were used as measures of area and individual 
socioeconomic status. Townsend deprivation index was obtained from the postcode of residence and 
has been derived from four census variables [12]; unemployment, non-car ownership, non-house 
ownership and household overcrowding. Professional qualifications were self-reported and coded as 
an ordinal variable; participants were asked, “Which of the following qualifications do you have? A 
categorical income variable was generated from self-reported income data. Further information in 
supplementary methods.   
2.2.1 Anthropometric  
Height was measured to the nearest centimetre (cm) using a Seca 202 height measure, and a Tanita 
BC-418 body composition analyser was used to measure weight to the nearest 0.1 kg. Both were used 
to estimate the body mass index (BMI) and the WHO criteria were applied to categorise participants 
into the following nutritional status: underweight <18.5, normal weight 18.5-24.9, overweight 25.0-
29.9 and obese ≥30.0 kg.m-2 [13]. Waist circumference (WC) was used to derive abdominal obesity, 
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defined as ≥88 cm for women or ≥102 cm for men [13]. Body composition was measured using 
bioimpedance (BIA) by trained nurses. High body fat was defined as body fat ≥ 26.9% in men, and ≥ 
38.6% in women. These cut-off points represent the two highest sex-specific quintiles in the UK 
Biobank population. Self-recalled birth weight was collected at baseline using a touchscreen 
questionnaire and categorised into tertiles: lower (<3.19 kg), middle (3.19 to 3.63 kg), and higher 
(>3.63 kg). 
2.2.3 Lifestyle  
Physical activity was based on self-report using the International Physical Activity Questionnaire (IPAQ) 
short form [14]. Total physical activity was computed as the sum of walking, moderate and vigorous 
activity, measured as metabolic equivalents (MET-hours/week). Total time spent in sedentary 
behaviours was derived from the sum of self-reported time spent sitting and classified as < 4 h/day 
and ≥ 4 h/day. Watching television was self-reported and categorised as lower (< 2 h/day), middle (3 
h/day) and higher (≥ 4 h/day). Self-reported smoking status was categorised as never, former or 
current smoker and self-reported sleep (<7 h/day, 7 to 9 h/day, and >9 h/day).  
Dietary information was collected via the Oxford WebQ; a web-based 24 h recall questionnaire which 
was developed specifically for use in large population studies and has been validated against an 
interviewer-administered 24 h recall questionnaire. The Oxford WebQ derives energy intake (total and 
from specific macronutrients), micronutrients (Vitamins: D, B12, B9 and B6; Minerals: potassium, 
calcium, magnesium and iron) and alcohol from the information recorded in McCance and 
Widdowson’s The Composition of Food, 5th edition [15]. All these variables were categorised in 
tertiles: lower, middle and higher intake.  
2.2.4 Health status  
Medical history at baseline was ascertained from a self-reported physician diagnosis of 345 diseases 
encoded using the ICD-10. Those diseases with a prevalence ≥1 % in UK Biobank were included in this 
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study (allergic-rhinitis,, angina, anxiety, asthma, back problem, breast cancer, cataract, chronic 
bronchitis, depression, dermatitis, diabetes, diverticulitis, gastric reflux, glaucoma, heart attack, hiatus 
hernia, high cholesterol, hypertension, hypothyroidism, irritable bowel syndrome, migraine, 
osteoarthritis, osteoporosis, pneumonia, psoriasis, rheumatoid arthritis, stroke, and venous 
thrombosis). Participants without medical diagnose for any of these 345 diseases were classified as 
healthy participants and used as the reference group.   
2.3 Statistical analyses 
Statistical analyses were performed using STATA 15 (StataCorp; College Station, TX). Descriptive 
characteristics of people with sarcopenia are presented as means with standard deviations (SD) for 
quantitative variables and percentages for categorical variables. To determine the main 
sociodemographic, health, anthropometric and lifestyle factors associated with sarcopenia; we used 
binary logistic regression analysis, where sarcopenia was the outcome coded as 0=normal according 
to the EWGSOP2 and 1=sarcopenia according to the EWGSOP2. The exposures were fitted into the 
model as categorical variables. For continuous variables, we derived tertiles of the exposure. 
Results are presented as odds ratios (OR) with their respective 95% CI. All analyses were adjusted for 
confounding factors, including age, sex, deprivation and educational attainment when these were not 
the exposures of interest. The analyses of smoking and health status were also adjusted for WC.  
The p-value used to infer statistical significance was corrected for multiple testing using the Bonferroni 
method, taking into account the number of comparisons made (n = 56) and the mean correlation 
between the variables tested. Accordingly, statistical significance was set at p<0.0008 for all analyses. 
3. Results 
Of the 469,858 white participants with information available for the three physical capability markers 
used to define sarcopenia and severe sarcopenia, 396,283 fulfilled the EWGSOP2 criteria for 
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sarcopenia and people without sarcopenia and were, therefore, included in the analyses. The main 
exclusion criteria are presented in Supplementary Figure 1. 
The main characteristics of the participants according to their sarcopenia status are presented in Table 
1. In summary, 0.4% of the study population had sarcopenia according to EWGSOP2 [1]. Compared to 
people without sarcopenia, people with sarcopenia were older (mean age 63.0 vs 56.1 years), had a 
lower height, weight and  WC. As a consequence, they had a lower prevalence of overweight, obesity 
and abdominal obesity, but a higher prevalence of underweight. Furthermore, people with sarcopenia 
had lower levels of physical activity and reported more falls and fractures in comparison to people 
without sarcopenia. 
The associations of sociodemographic factors with sarcopenia are shown in Figure 1. Women, age 
older than 56-years-old and lower levels of education were associated with sarcopenia. Underweight 
participants were almost eight times more likely to have sarcopenia, in comparison to normal-weight 
individuals (OR: 7.60 [95% CI: 6.08 to 9.50]). Conversely, people who were overweight, obese, or had 
higher central obesity and body fat were less likely to have sarcopenia (Figure 2). Furthermore, whose 
birth weight was in the lowest tertile were more likely to have sarcopenia compared to people in the 
middle tertile (OR: 1.47 [95% CI: 1.26 to 1.72]). 
Figures 2 and 3 show the lifestyle factors associated with sarcopenia. Using the corrected p-value, long 
sleep, watching television more than 4 h/day, being physically active and being a previous smoker, 
were not significantly associated with sarcopenia in this study. On the other hand, people in the 
highest tertile of energy and protein intake were less likely to have sarcopenia in comparison to those 
in the lowest tertile (Figure 3). In terms of micronutrients, a higher intake of vitamins and minerals 
was associated with a lower odds of sarcopenia. Of these, the highest tertiles of intake for B12, B9, 
calcium, potassium, and magnesium were all associated with the lowest likelihood of sarcopenia 
(Figure 3).  
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Of the 28  diseases analysed, 24 were associated with sarcopenia. The strongest associations were 
observed for rheumatoid arthritis (OR: 16.3 [95% CI: 12.8 to 20.8]), followed by chronic bronchitis 
(4.84 [95% CI: 3.49 to 6.70]) osteoporosis (OR: 4.40 [95% CI: 3.56 to 5.46]), stroke (OR: 3.49 [95% CI: 
2.33 to 5.22]) and psoriasis (OR: 3.44 [95% CI: 2.25 to 5.26]) (Figure 4). 
4. Discussion  
The study has shown that using the current EWGSOP2 definition [1], a variety of different 
sociodemographic (age, women, lower education and higher deprivation), anthropometric 
(underweight and lower birth weight), and diseases were identified with a higher odds of having 
sarcopenia. Amongst these risk factors, women, adults older than 65 years, underweight people and 
those with a diagnosis of rheumatoid arthritis were quantitatively the most likely to have sarcopenia. 
On the other hand, overweight, obese, as well as those reporting a higher intake of energy, protein, 
vitamins (B12, B9) and minerals (potassium, calcium, and magnesium), were quantitatively the least 
likely to have sarcopenia. In this context, this study adds novel evidence to our knowledge of 
sarcopenia. Taking into account that low levels of physical capability and sarcopenia are strong 
predictors of premature mortality, cardiovascular and neurodegenerative diseases in the middle- and 
older-aged populations [16], the current data identifies potentially modifiable factors fundamental for 
both the prevention and management of the disease. There is also evidence of the potential 
association between a few novel lifestyle factors (such as longer sleep duration and shorter TV viewing) 
and sarcopenia risk. However, these factors did not reach the usual threshold of statistical significance 
after correcting for multiple testing. Further studies will be required to delineate the roles of these 
factors.  
Previous cross-sectional studies have also investigated factors which are more likely to be associated 
with sarcopenia using different sarcopenia classifications and cut-off points [3, 4, 7]. However, to our 
knowledge, only one study, on a Japanese population, has used the new definition of sarcopenia to 
investigate potential risk factors [8]. In that cross-sectional study, Su et al. explored a limited number 
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of factors associated with sarcopenia and demonstrated that people who had diabetes and those who 
were taking more than four medications a day were 3.6 and 2.6 times more likely to having sarcopenia 
[8].  
Age, lower levels of education and income have also previously been associated with a higher 
likelihood of sarcopenia in both European and non-European populations, following the sarcopenia 
definitions from different working groups [3-6, 17]. In fact, not having a formal education was 
associated with almost three times higher odds of sarcopenia in a Nigerian population while in Italy, 
higher education was associated with 15% lower odds of sarcopenia [5, 6]. In contrast, and although 
women experiment an earlier loss of muscle mass and a major decline in hormones that are important 
for the muscle (e.g. estrogen), not all studies have identified the same association with sex. Indeed, 
Santos et al. and Bae & Kim demonstrated that both Brazilian and Korean men were four and three 
times more likely, respectively, of having sarcopenia than women [3, 18] while Adebusoye et al. 
showed that Nigerian women had three times higher odds of sarcopenia than men [6]. These 
differences may be explained by the different diagnostic criteria and cut-off points used to define 
sarcopenia, and also because of the age of the populations investigated.  
During ageing, the risk of malnutrition may occur independently of sarcopenia and other diseases. 
However, changes in body composition could be another important factor associated with a higher 
likelihood of sarcopenia[19]. In sarcopenic people, underweight has been associated with a higher 
likelihood of sarcopenia [7], more often in hospitalised people [20] and even when other cut-off points 
were used to define underweight (BMI <22kg/m2)[4]. Although anorexia and underweight are 
recognised causes of sarcopenia [1],  previous studies have highlighted that sarcopenia increases the 
risk of obesity and poor metabolic health [21]. In other words, obesity exacerbates sarcopenia and 
vice versa (sarcopenic obesity) [1]. However, and similar to the findings of Han et al. [17] and Volpato 
et al. [5], in this study, people with higher body weight were less likely to have sarcopenia. A possible 
explanation may be that obesity represents a possible protective factor against the loss of lean mass 
in older adults.  
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Interestingly, and similar to other studies, lower birth weight was positively associated with 
sarcopenia [2, 22], highlighting the relevance of the correct nutrition and balance even since the 
intrauterine stage.  
Perhaps surprisingly, we did not find any associations between sarcopenia and lower levels of physical 
activity, sedentary behaviours, smoking, and short and long sleep duration using the corrected p-value. 
However, other studies have shown a significant association between these factors and sarcopenia. 
For example, Gianoudis et al. identified that per 1-hour increase in sedentary behaviour the odds of 
sarcopenia was 33% higher [23] while Steffl et al. demonstrated, in a meta-analysis of 40,007 
individuals, that any form of physical activity was associated with a 55% lower likelihood of sarcopenia 
[24]. Furthermore, Hu et al. showed that sleep duration had a U-shape relationship with sarcopenia, 
with a higher odds associated with both short (<6 h/day) and long (>8 h/day) sleep durations [25].      
In terms of dietary patterns, in the current study, people with a higher intake of energy and protein 
were less likely to have sarcopenia. However, Granic and colleagues reported different results in the 
85+ study (another UK prospective study), since the risk of sarcopenia was higher in people with a 
traditional British diet, i.e., high in butter, red meat and potato, even when the protein consumption 
was ≥ 1 g/kg BW/day [26]. Conversely, several vitamins and minerals are important cofactors and 
essential contributors to muscle, bone, and neurological integrity [27]. As a result, it is no surprise that 
in this study, higher intake of these nutrients was associated with a lower likelihood of sarcopenia. In 
fact, higher levels of dietary calcium and vitamin D have been found to be associated with a lower 
prevalence of sarcopenia [27]. Magnesium, selenium and calcium have also shown to be promising 
minerals to prevent or treat sarcopenia [28]. However, according to the findings of Beaudart et al., 
sarcopenic individuals seem to intake lower amount of potassium, magnesium, iron, calcium and 
vitamins (E and C) in comparison to people without sarcopenia [29].   
Two types have been recognised for sarcopenia: primary (associated with age) and secondary 
(associated with diseases). In this context, chronic obstructive pulmonary diseases, cancer, heart 
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failure, and diabetes have all been associated with higher odds of sarcopenia [2]. In relation to 
diabetes, there is evidence of a bi-directional association with sarcopenia [17]. However, using the 
new EWGSOP2, we did not find any significant association between diabetes and sarcopenia.  
According to the EWGSOP2 definition, neurological disorders may become a predisposing factor for 
sarcopenia as well [1]. In this study, in common with previous studies [30], there was a significant 
association between sarcopenia and migraine, depression, and anxiety. Finally, it is important to 
highlight that some acute and chronic illnesses require periods of bed rest or hospitalisation during 
which muscle quantity and quality may be lost, thereby, contributing to secondary sarcopenia in both 
middle-aged and old-aged populations [2]. 
4.1 Limitations 
UK Biobank is not representative of the UK population in terms of lifestyle and disease prevalence  
[31]. Therefore, whilst estimates of effect sizes can be generalised, summary statistics should not. Use 
of UK Biobank provided the opportunity to test our research question in a very large general 
population cohort as well as the opportunity to work with information collected using validated and 
standardised methods. On the other hand, dual-energy X-ray absorptiometry (DXA) is the most 
commonly used method for deriving muscle mass because it can provide a reproducible estimation of 
the appendicular skeletal muscle mass in a few minutes. In the UK Biobank, only 5,000 participants 
had data available for DXA. However, in this study, muscle mass measured using BIA showed a high 
correlation with DXA (r=0.868, p<0.0001).  
As in any observational study, residual confounding is possible, and due to the cross-sectional study 
design, temporal relationships could not be established in order to exclude the possibility of reverse 
causation. Both limitations mitigate against inferring causation. Finally, whilst we were able to study 
a wide range of factors of interest we could not study all. For example, we did not have data on omega-
3 and other antioxidants shown in other studies to be associated with sarcopenia [32]. Therefore,  
future studies using the EGWSOP2 classification should investigate these factors.  
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4.2 Conclusions  
Multiple sociodemographic, health, anthropometric and lifestyle factors were associated with a higher 
and lower likelihood of sarcopenia. Among these, women, adults older than 65 years, people with 
underweight and those with rheumatoid arthritis showed the highest likelihood while being 
overweight or obese, and a higher intake of energy, protein, vitamins (B12, B9) and minerals 
(potassium, calcium, and magnesium) showed the lowest likelihood. Considering that with the 
increase in the ageing population, the illnesses associated are likely to rise as well, public health 
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Table 1. Characteristics population without and with sarcopenia 
 No sarcopenia (normal) Sarcopenia 
Socio-demographics   
Total n 394,605  1,678  
Prevalence (%) (83.9%) (0.4%) 
Age (years), mean (SD) 56.1 (8.1) 63.0 (5.3) 
Deprivation index, mean (SD) -1.6 (2.9) -1.3 (3.0) 





215,924 (54.9)        
138,609 (35.2)        
38,877 (9.9) 
 
993 (59.5)        
529 (31.7)        
147 (8.8) 
Obesity-related markers   
Height (meters), mean (SD) 1.69 (0.09) 1.61 (0.07) 
Body weight (kg), mean (SD) 78.0 (15.2) 59.6 (8.3) 
BMI, mean (SD) 27.1 (4.4) 22.9 (2.9) 
BMI Categories, n (%) 
Underweight (<18.5 kg.m-2) 
Normal weight (18.5-24.9 kg.m-2) 
Overweight (25.0 to 29.9 kg.m-2) 
Obese (≥30.0 kg.m-2) 
 
1,480 (0.4)         
131,731 (33.5)        
173,553 (44.1)        
86,692 (22.0) 
 
102 (6.1)         
1,171 (69.8)        
392 (23.3)        
13 (0.8) 
Waist Circumference (cm) 89.7 (12.9) 78.2 (8.8) 
Central Obesity, n (%) 121,990 (31.0) 224 (13.4) 
% Body fat, mean (SD) 30.7 (8.3) 36.1 (6.4) 
Fitness and Physical activity   
Total PA (MET.h-1.week-1), mean (SD) 3018.3 (3286.7) 2609.6 (2744.5) 
TV viewing (h.day-1), mean (SD) 2.7 (1.5) 3.2 (1.7) 
Total Sedentary behaviour (h.day-1), mean (SD) 5.0 (2.2) 4.6 (2.0) 
Health status, n (%)   
Diabetes history 15,062 (3.8) 28 (1.7) 
CVDs history 106,513 (27.0) 443 (26.5) 
High blood pressure history 88,983 (22.6) 343 (20.5) 
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Fractures 19,919 (56.5) 201 (80.1) 
Falls, n (%) 
No falls 
Only one fall 









BMI: body mass index; n: number; h.day-1: hour/day; PA: physical activity; MET: metabolic-equivalent;; SD: standard 




Figure 1. Sociodemographic factors associated with sarcopenia. 
Data are presented as odds ratios (OR) with their respective 95% CI. All analyses were adjusted for 
confounding factors, including age, sex, deprivation and education attainment when these were not 






Figure 2. Anthropometric and Lifestyle factors associated with sarcopenia.. 
Data are presented as odds ratios (OR) with their respective 95% CI. All analyses were adjusted for 
confounding factors, including age, sex, deprivation and education attainment. Besides, smoking was 






Figure 3. Nutritional factors associated with Sarcopenia. 
Data are presented as odds ratios (OR) with their respective 95% CI. All analyses were adjusted for 
confounding factors, including age, sex, deprivation and education attainment.  
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Figure 4. Diseases associated with sarcopenia. 
Data are presented as odds ratios (OR) with their respective 95% CI. All analyses were adjusted for 
confounding factors, including age, sex, deprivation and education attainment and WC.  
 
 
